Literature DB >> 11214923

Specific determination of the proteinase K-resistant form of the prion protein using two-site immunometric assays. Application to the post-mortem diagnosis of BSE.

J Grassi1, C Créminon, Y Frobert, P Frétier, I Turbica, H Rezaei, G Hunsmann, E Comoy, J P Deslys.   

Abstract

The aim of this work was to establish an immunological test suitable for specifically detecting PrPres in tissues from animals or humans developing TSEs. We chose to use as detection method a conventional two-site immunometric assay (sandwich immunoassay) because over the last 20 years this technique has clearly been shown to be more sensitive and specific than other tests. We have established numerous two-site immunometric assays based on the use of monoclonal antibodies and suitable for measurement of PrPsen in various mammalian species (human, bovine, ovine, mouse and hamster). A detection limit below 100 pg/ml was estimated from standard curves established using ovine recombinant PrP. PrPres was selectively detected by processing samples (currently brain homogenates) to enable specific purification and concentration of PrPres, which was finally solubilized by a strong denaturing treatment. This sample-processing procedure can be achieved within 30 minutes. The capacity of this test to detect bovine PrPres was estimated in the framework of an evaluation study organized by the Directorate-General XXIV of the European Commission during May 1999. On this occasion, a blind test on 1400 brain stem samples taken from either healthy (1000) or BSE-infected (300) cows demonstrated 100% sensitivity and specificity. In addition, dilution experiments showed that the test can significantly detect PrPres in homogenates diluted 1/300 and was at least as sensitive as a conventional bioassay performed on mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214923     DOI: 10.1007/978-3-7091-6308-5_19

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  6 in total

1.  Evaluation of quinacrine treatment for prion diseases.

Authors:  A Barret; F Tagliavini; G Forloni; C Bate; M Salmona; L Colombo; A De Luigi; L Limido; S Suardi; G Rossi; F Auvré; K T Adjou; N Salès; A Williams; C Lasmézas; J P Deslys
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental bovine spongiform encephalopathy in sheep by use of Western blotting and immunohistochemical methods.

Authors:  Stéphane Lezmi; Stuart Martin; Stéphanie Simon; Emmanuel Comoy; Anna Bencsik; Jean-Philippe Deslys; Jacques Grassi; Martin Jeffrey; Thierry Baron
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Highly Sensitive and Specific Detection of Staphylococcal Enterotoxins SEA, SEG, SEH, and SEI by Immunoassay.

Authors:  Cécile Féraudet Tarisse; Céline Goulard-Huet; Yacine Nia; Karine Devilliers; Dominique Marcé; Chloé Dambrune; Donatien Lefebvre; Jacques-Antoine Hennekinne; Stéphanie Simon
Journal:  Toxins (Basel)       Date:  2021-02-09       Impact factor: 4.546

4.  Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.

Authors:  Jean-Noël Arsac; Dominique Bétemps; Eric Morignat; Cécile Féraudet; Anna Bencsik; Denise Aubert; Jacques Grassi; Thierry Baron
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

5.  Rapid typing of transmissible spongiform encephalopathy strains with differential ELISA.

Authors:  Stéphanie Simon; Jérôme Nugier; Nathalie Morel; Hervé Boutal; Christophe Créminon; Sylvie L Benestad; Olivier Andréoletti; Frédéric Lantier; Jean-Marc Bilheude; Muriel Feyssaguet; Anne-Gaëlle Biacabe; Thierry Baron; Jacques Grassi
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

6.  Transmission of atypical bovine prions to mice transgenic for human prion protein.

Authors:  Vincent Béringue; Laëtitia Herzog; Fabienne Reine; Annick Le Dur; Cristina Casalone; Jean-Luc Vilotte; Hubert Laude
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.